Strata Critical Medical, Inc. (SRTA)
NASDAQ: SRTA · Real-Time Price · USD
5.08
+0.13 (2.63%)
Apr 28, 2026, 4:00 PM EDT - Market closed
Strata Critical Medical Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Market Capitalization | 439 | 415 | 333 | 263 | 257 | 623 | |
| Market Cap Growth | 104.18% | 24.81% | 26.33% | 2.71% | -58.82% | -13.72% | |
| Enterprise Value | 381 | 343 | 220 | 115 | 71 | 320 | |
| Last Close Price | 5.08 | 4.81 | 4.25 | 3.53 | 3.58 | 8.83 | |
| PE Ratio | 10.09 | 10.05 | - | - | - | - | |
| PS Ratio | 2.23 | 2.11 | 2.27 | 1.17 | 1.76 | 9.28 | |
| PB Ratio | 1.58 | 1.49 | 1.50 | 1.12 | 0.94 | 2.14 | |
| P/TBV Ratio | 3.06 | 2.90 | 1.68 | 1.52 | 1.36 | 2.46 | |
| EV/Sales Ratio | 1.93 | 1.74 | 1.50 | 0.51 | 0.49 | 4.76 | |
| Debt / Equity Ratio | 0.01 | 0.01 | 0.01 | 0.11 | 0.07 | 0.00 | |
| Net Debt / Equity Ratio | -0.21 | -0.21 | -0.55 | -0.60 | -0.63 | -0.96 | |
| Net Debt / EBITDA Ratio | 10.15 | 10.15 | 6.83 | 3.77 | 3.88 | 9.05 | |
| Net Debt / FCF Ratio | 0.99 | 0.99 | 3.65 | 4.11 | 4.59 | 12.72 | |
| Asset Turnover | 0.68 | 0.68 | 0.53 | 0.73 | 0.44 | - | |
| Quick Ratio | 5.11 | 5.11 | 6.37 | 5.27 | 7.63 | 22.49 | |
| Current Ratio | 6.38 | 6.38 | 7.07 | 5.81 | 8.20 | 23.07 | |
| Return on Equity (ROE) | -8.01% | -8.01% | -7.08% | -22.04% | -9.63% | - | |
| Return on Assets (ROA) | -2.71% | -2.71% | -4.78% | -9.01% | -9.55% | - | |
| Return on Capital Employed (ROCE) | -4.10% | -4.10% | -9.00% | -17.20% | -16.90% | -10.00% | |
| Earnings Yield | 9.42% | 9.95% | -8.20% | -21.29% | -10.63% | -5.93% | |
| FCF Yield | -13.32% | -14.08% | -10.03% | -13.08% | -14.76% | -3.55% | |
| Buyback Yield / Dilution | -5.93% | -5.93% | -5.41% | -3.21% | -31.65% | -26.18% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.